Omnicell Appoints New CTO to Drive Technological Innovation

Omnicell, Inc. has announced the appointment of Dr. Perry A. Genova as Senior Vice President and Chief Technology Officer, effective March 31, 2025. Bringing over 25 years of industry experience, Dr. Genova will lead the technology strategy at Omnicell. His expertise will aid in addressing critical medication and supply management challenges with a focus on advancing towards the Autonomous Pharmacy model, significantly impacting the pharmacy and nursing care landscape. 

Since 1992, Omnicell has been a frontrunner in revolutionising pharmacy and nursing care, providing innovative solutions that prioritise both clinical and business outcomes. The company’s comprehensive suite of robotics, intelligent software, and analytics tools is designed to help healthcare facilities uncover cost savings and improve operational efficiency. Dr. Genova, renowned for his contributions in medical device and life sciences sectors, has held major roles, including SVP of Research and Development at EndoQuest Robotics and CEO of Centauri Robotic Surgical Systems. With 58 U.S. patents, his achievements swell with inventions like a class-leading insulin device and developments in medical technologies.

With Dr. Genova at the helm of technological strategies, Omnicell is poised for further advancement in transforming medication management and delivering significant value to its customers. His focus on trust and collaboration with stakeholders will drive the company’s mission to revolutionise care delivery through innovative outcomes. As Omnicell strides towards realising the Autonomous Pharmacy, this strategic appointment marks a pivotal step in strengthening its industry leadership.

For the latest updates and in-depth insights into the world of Service Engineering, including breakthrough treatments, industry trends, and regulatory news, contact James Dolan today!